Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03414450 |
| Title | Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies |
| Recruitment | Withdrawn |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | D3 (Drug Discovery and Development), A*STAR Research Entities |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Winship Cancer Institute, Emory University | Atlanta | Georgia | 30322 | United States | Details | |
| The Center for Cancer and Blood Disorders | Bethesda | Maryland | 20874 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| Oregon Health & Science University | Portland | Oregon | 97239 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Singapore General Hospital | Singapore | 169608 | Singapore | Details |